What’s new for the clinician – summaries of recently published papers (March 2024)


  • V Yengopal


periodontology, molecular


Alzheimer’s disease (AD), which is characterised by insidious onset and progressive deterioration in behavioural and cognitive functions, is a neurodegenerative disease that commonly affects the central nervous system (CNS).1 The prevalence of AD increases with advancing age and, after the age of 65, the risk of AD doubles every five years. It is more common in women than men.1 It is thought that chronic inflammatory diseases and conditions in peripheral organs such as cardiovascular disease, diabetes and
periodontitis can affect the inflammatory state in the CNS and exacerbate the molecular pathology of AD.1


Download data is not yet available.


Metrics Loading ...


Karaduran K, Aydogdu A, Gelisin O, Gunpinar S. Investigating the potential clinical impact of periodontitis on the progression of Alzheimer’s disease: a prospective cohort study. Clinical Oral Investigations. 2023 Dec 30;28(1):67

Lindfors N, Ekestubbe A, Frisk F, Lund H. Is cone-beam computed tomography (CBCT) an alternative to plain radiography in assessments of dental disease? A study of method agreement in a medically compromised patient population. Clinical Oral Investigations. 2024 Jan 30;28(2):12




How to Cite

Yengopal, V. (2024). What’s new for the clinician – summaries of recently published papers (March 2024). South African Dental Journal, 79(02), 109–112. Retrieved from https://journals.assaf.org.za/index.php/sadj/article/view/18437



Evidence-based Dentistry

Most read articles by the same author(s)

1 2 3 > >>